ANDA 76165, held by Cr Double Crane. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 76165 (Fluoxetine Hydrochloride), held by Cr Double Crane, was first approved by FDA on Feb 1, 2002, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 1, 2002 | Original application | Approved |
| Fluoxetine HydrochlorideEQ 10MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Fluoxetine HydrochlorideEQ 20MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Jul 7, 2008 | Supplement 4Labeling | Approved | None posted |
| Oct 24, 2007 | Supplement 3Labeling | Approved | None posted |
| Oct 5, 2006 | Supplement 2Labeling | Approved | None posted |
| Feb 1, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters